Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol PR versus oxycodone/naloxone PR for severe chronic low back pain with a neuropathic pain component
2012-002943-11Phase 3Completed
- Sponsor
- Grünenthal GmbH
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in chronic low back pain (CLBP) and Neuralgia comparing Tapentadol PR with Oxycodone/naloxone PR (2 arms). Started Dec 2012; status: completed.
02
Drugs
tapentadoloxycodone + naloxone
03
Conditions
chronic low back pain (CLBP)Neuralgia
Beyond the preview
Go deeper on 2012-002943-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002943-11.